Showing 1 to 2 of 2 results


FDA Issues Safety Warnings for Boston Scientific Heart Devices
The FDA issued safety warnings for two Boston Scientific heart devices—the Endotak Reliance defibrillator, linked to 386 serious injuries and 16 deaths, and the Watchman device, linked to 120 serious injuries and 17 deaths—prompting concerns about device safety and the company's financial standing.
FDA Issues Safety Warnings for Boston Scientific Heart Devices
The FDA issued safety warnings for two Boston Scientific heart devices—the Endotak Reliance defibrillator, linked to 386 serious injuries and 16 deaths, and the Watchman device, linked to 120 serious injuries and 17 deaths—prompting concerns about device safety and the company's financial standing.
Progress
24% Bias Score

BSX Earnings: 60% Historical Probability of Positive Post-Earnings Returns
Boston Scientific (BSX) is set to release earnings on July 23, 2025; its stock has shown a positive one-day return after earnings 60% of the time over the past five years, with a median gain of 3.2%, suggesting a potential trading strategy, although performance is not guaranteed.

BSX Earnings: 60% Historical Probability of Positive Post-Earnings Returns
Boston Scientific (BSX) is set to release earnings on July 23, 2025; its stock has shown a positive one-day return after earnings 60% of the time over the past five years, with a median gain of 3.2%, suggesting a potential trading strategy, although performance is not guaranteed.
Progress
48% Bias Score
Showing 1 to 2 of 2 results